Table 2 |
|||||
|
Percent blood glucose reduction produced by T. chebula after chronic administration in streptozotocin-induced diabetic rats |
|||||
|
Group (n = 5) |
Dose (mg/kg) |
Percent blood glucose reduction |
|||
|
|
|||||
|
1 |
2 |
3 |
4 (Weeks) |
||
|
|
|||||
|
Control |
---- |
-19.72 ± 8.05 |
-14.35 ± 4.92 |
-7.06 ± 4.28 |
-12.48 ± 7.55 |
|
T. chebula |
300 |
38.75 ± 8.09* |
45.20 ± 11.64* |
48.10 ± 5.25* |
53.09 ± 3.14* |
|
Glibenclamide |
0.04 |
48.09 ± 10.90* |
55.75 ± 8.03* |
58.88 ± 5.08* |
60.10 ± 2.70* |
|
|
|||||
|
Values are represented as mean ± S.E.M.; n = number of animals per group Significant difference from control group at identical times, *P < 0.01 |
|||||
|
Rao and Nammi BMC Complementary and Alternative Medicine 2006 6:17 doi:10.1186/1472-6882-6-17 |
|||||